who should not take bpc 157 YOU Be Taking BPC-157 Peptides? – Dr Brad Stanfield What is BPC-157? | Everything

Bioavailability following subcutaneous injection is estimated at approximately 80%, substantially higher than oral administration, where peptide degradation in the gastrointestinal tract limits systemic exposure

I would encourage patients to speak to their practice if they have concerns about their B12 treatment

compounding pharmacies

You can find out more about the impact of the UKs B12 crisis and why early detection is so important

- Individuals with weakened immune systems - Those looking to boost their antioxidant levels - People recovering from illness or surgery - Individuals exposed to high levels of stress or environmental toxins - Anyone seeking to enhance overall wellness 2

If yes, no specific follow up for B 12 is required